Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Other Current Assets
Current assets not reported separately, such as prepaid expenses.
Other Current Assets history
Currency unavailable · from the balance sheet
No Other Current Assets data reported for this period type.
Other Current Assets vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $32.28M USD | +57.7% | +15.0% | 7.4% | |
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $20.8M USD | — | +976.7% | 5.3% |
| Mar 2026 | $17.12M USD | — | +64.9% | 4.1% | |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | $7.86M USD | +40.6% | — | 1.6% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | $6.64M USD | +366.0% | +63.3% | 2.5% |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $6.36M USD | +15.4% | +443.0% | 4.1% |
| Mar 2026 | $4.91M USD | +47.8% | — | 1.8% | |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | +47.8% | +64.9% | 4.1% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.